Full Professor(heuristic)

Ovarian cancer diagnosis and treatment · Reproductive Medicine

Compare more Reproductive Medicine professors.

h-index56
i10-index119
Publications294
Citations29,460

Grants

1 total · 0 active

NIH #R01CA123249

Regulation of Serine Protease HtrA1 and Chemoresponse

Amount
$300K–$400K
Period
2008-04-012013-01-31
PIs
2

Awarded at MAYO CLINIC ROCHESTER

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

1 total · 0 active

NIH #R01CA123249

Regulation of Serine Protease HtrA1 and Chemoresponse

Amount
$300K–$400K
Period
2008-04-012013-01-31
PIs
2

Awarded at MAYO CLINIC ROCHESTER

Recent Public Signals

  1. New paper: Differential effects of GPX4 inhibitor on drug-tolerant persister ovarian cancer cells (Gynecologic Oncology)2026-04-23
  2. New preprint: Role of drug induced nuclear CTSL (nCTSL) in DNA damage response in cancer- therapeutic implications2025-01-14

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

ORCID: 0000-0003-4744-8374

Professor Insights

Career Trajectory